Chief Financial Officer
Mr. Naor has over 20 years of global work experience as a senior finance executive in public and private pharma, biotech, and medtech companies.
He managed organizations with up to $2.5 billion in sales and built top-performing finance & accounting, IR, legal, contracting & pricing, IT, and big data analytics functions. Amongst his roles, Mr. Naor has served as the Chief Financial Officer of Arbor Pharmaceuticals and supported its strategic pivot. He was also the CFO US / Americas of Mölnlycke Healthcare, where he played a pivotal role in its growth and profitability improvement and was the founder of UCB’s global Portfolio Management and Resource Allocation function, as well as the company’s US Chief Financial Officer. Earlier in his career, he held several finance leadership positions with AstraZeneca, served as a financial consultant and investment banker, worked as an auditor with KPMG, and prior to that practiced commercial law. He continues to advise and serve as a board member for emerging life sciences and technology companies.
Mr. Naor holds a Master of Business Administration from IMD Business School in Switzerland, a master’s degree in law (LL.M.) from Hamburg University in Germany, and bachelor’s degrees in law (LL.B.) and in accounting from the Tel-Aviv University in Israel. Mr. Naor is also a CFA® charterholder.